ESSA Pharma (EPIX) Competitors

Olema Pharmaceuticals (NASDAQ:OLMA) and ESSA Pharma (NASDAQ:EPIX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends.

Is OLMA or EPIX more profitable?

ESSA Pharma's return on equity of -24.61% beat Olema Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Olema Pharmaceuticals	N/A	-53.56%	-47.86%
ESSA Pharma	N/A	-24.61%	-23.87%

Does the MarketBeat Community believe in OLMA or EPIX?

ESSA Pharma received 310 more outperform votes than Olema Pharmaceuticals when rated by MarketBeat users. Likewise, 75.87% of users gave ESSA Pharma an outperform vote while only 72.22% of users gave Olema Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Olema Pharmaceuticals	Outperform Votes 39 72.22%	Underperform Votes 15 27.78%
ESSA Pharma	Outperform Votes 349 75.87%	Underperform Votes 111 24.13%

Do analysts rate OLMA or EPIX?

Olema Pharmaceuticals currently has a consensus target price of $24.50, suggesting a potential upside of 502.71%. ESSA Pharma has a consensus target price of $2.00, suggesting a potential upside of 17.65%. Given Olema Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe Olema Pharmaceuticals is more favorable than ESSA Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Olema Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
ESSA Pharma	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has stronger valuation & earnings, OLMA or EPIX?

ESSA Pharma is trading at a lower price-to-earnings ratio than Olema Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Olema Pharmaceuticals	N/A	N/A	-$96.65M	-$2.01	-2.02
ESSA Pharma	N/A	N/A	-$28.54M	-$0.63	-2.70

Do institutionals and insiders believe in OLMA or EPIX?

91.8% of Olema Pharmaceuticals shares are owned by institutional investors. Comparatively, 75.1% of ESSA Pharma shares are owned by institutional investors. 16.4% of Olema Pharmaceuticals shares are owned by company insiders. Comparatively, 15.5% of ESSA Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has more volatility & risk, OLMA or EPIX?

Olema Pharmaceuticals has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500. Comparatively, ESSA Pharma has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500.

Does the media prefer OLMA or EPIX?

In the previous week, Olema Pharmaceuticals had 1 more articles in the media than ESSA Pharma. MarketBeat recorded 4 mentions for Olema Pharmaceuticals and 3 mentions for ESSA Pharma. ESSA Pharma's average media sentiment score of 1.71 beat Olema Pharmaceuticals' score of 0.00 indicating that ESSA Pharma is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Olema Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ESSA Pharma	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Olema Pharmaceuticals beats ESSA Pharma on 8 of the 15 factors compared between the two stocks.